Rising Infertility Rates Driving Growth Of The Chorionic Gonadotropin Market Driver: A Major Catalyst in the Evolution of the Chorionic Gonadotropin Market in 2025

How Is the Chorionic Gonadotropin Market Projected to Grow, and What Is Its Market Size?
The market for chorionic gonadotropin has seen consistent growth in the past few years. It is projected to increase from $1,260 million in 2024 to $1,340 million in 2025, reflecting a compound annual growth rate (CAGR) of 4.4%. Factors contributing to this growth during the historic period include heightened awareness of hCG among medical professionals and patients, more frequent use for hormonal imbalance disorder treatments, improved affordability, enhancements in healthcare services, and a rising demand for assisted reproduction treatments.

A consistent growth pattern is anticipated in the chorionic gonadotropin market size over the next several years. The market is projected to escalate to $1,710 million in 2029, with a compound annual growth rate (CAGR) of 4%. This expansion during the forecast timeline can be linked to the increasing instances of infertility conditions, heightened awareness on reproductive health, a surge in the acceptance of assisted reproductive technologies, a rampant growth of hypogonadism among the aging population, and a vast improvement in the healthcare network. The forecast period's significant trends include technological evolution, progression in recombinant technology, a boom in assisted reproductive technology, vigorous investments in R&D, and a revolution in drug delivery frameworks and formulations.

What Are the Key Drivers Behind the Growth of the Chorionic Gonadotropin Market?
The increasing incidence of fertility issues is set to drive the expansion of the chorionic gonadotropin market. Infertility, defined as a failure to conceive after a year of regular, unprotected sex for those under 35, or after six months for those 35 and above, is on the rise mainly due to delayed parenthood and lifestyle choices like obesity and smoking which negatively influence reproductive health. Chorionic Gonadotropin (hCG) is incorporated in fertility treatments to stimulate ovulation, maintain pregnancy during the luteal phase, and boost testosterone production in men, thus addressing several fertility issues. For instance, the World Health Organization (WHO) reported in April 2023 that approximately 17.5% of the adult population worldwide - or 1 in 6 people - experiences infertility, underlining the critical need for enhanced access to cost-effective, high-grade fertility care for those impacted. Hence, the growing incidence of infertility problems is boosting the chorionic gonadotropin market's growth. The expansion of the chorionic gonadotropin market is also being driven by the rise in assisted reproductive technologies. Assisted reproductive technologies (ART), which refer to medical procedures that assist individuals and couples in achieving pregnancy when natural conception is impossible, are becoming increasingly popular owing to greater infertility rates, medical advancements, delayed childbearing, and improved accessibility. Chorionic gonadotropin (hCG) is employed in ART procedures to trigger ovulation and support the luteal phase following an embryo transfer, ensuring successful fertilization and early-term pregnancy. For example, data from MJH Life Sciences in April 2024 indicates that the number of ART cycles increased, with egg freezing cycles growing from 24,560 in 2021 to 29,803 in 2022. Hence, the growing use of assisted reproductive technologies is propelling the growth of the chorionic gonadotropin market.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19888&type=smp

Who Are the Major Industry Players Fueling Chorionic Gonadotropin Market Expansion?
Major companies operating in the chorionic gonadotropin market include Ferring Pharmaceuticals

Which Key Developments Are Influencing the Chorionic Gonadotropin Market?
A primary trend in the chorionic gonadotropin marketplace revolves around creating groundbreaking alternatives such as pregnancy checks using saliva in a bid to enhance efficiency, accuracy, and user-friendliness. Essentially, a saliva-based pregnancy check is a non-intrusive method of diagnosis that determines pregnancy by checking a woman's saliva for traces of the human chorionic gonadotropin (hCG) hormone, typically produced during pregnancy. In fact, in June 2023, an Israeli biotech firm known as Salignostics introduced the first-ever saliva-based pregnancy check globally. This unique product lets women verify pregnancy by using their saliva sample, rather than urine, to identify the presence of the hCG hormone, delivering results in a brief duration of between 5 and 15 minutes. Salistick provides a testing experience that is both convenient and comfortable, allowing users to conduct tests anywhere and share the momentous occasion with loved ones or significant others.

How Is the Segmentation of the Chorionic Gonadotropin Market Defined?
The chorionic gonadotropinmarket covered in this report is segmented -

1) By Type: Human Chorionic Gonadotropin; Animal Chorionic Gonadotropin
2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
3) By Therapeutic Application: Male Hypogonadism; Female Infertility Treatment; Oligospermic Treatment; Cryptorchidism Treatment; Chronic Pain; Other Therapeutic Applications
4) By End User: Research Institutions; Pharmaceutical Companies

Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/chorionic-gonadotropin-global-market-report

What Is the Leading Region in the Chorionic Gonadotropin Market?
North America was the largest region in the chorionic gonadotropin market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the chorionic gonadotropin market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Is Covered In The Chorionic Gonadotropin Global Market Report?

- Market Size Analysis: Analyze the chorionic gonadotropin Market Size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the chorionic gonadotropin market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall chorionic gonadotropin market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the chorionic gonadotropin market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19888

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.